BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 24745332)

  • 1. Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms.
    Xiao S; Yosef N; Yang J; Wang Y; Zhou L; Zhu C; Wu C; Baloglu E; Schmidt D; Ramesh R; Lobera M; Sundrud MS; Tsai PY; Xiang Z; Wang J; Xu Y; Lin X; Kretschmer K; Rahl PB; Young RA; Zhong Z; Hafler DA; Regev A; Ghosh S; Marson A; Kuchroo VK
    Immunity; 2014 Apr; 40(4):477-89. PubMed ID: 24745332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging landscape of RORγt biology.
    Lee JS; Cua DJ
    Immunity; 2014 Apr; 40(4):451-2. PubMed ID: 24745326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists.
    Skepner J; Trocha M; Ramesh R; Qu XA; Schmidt D; Baloglu E; Lobera M; Davis S; Nolan MA; Carlson TJ; Hill J; Ghosh S; Sundrud MS; Yang J
    Immunology; 2015 Jul; 145(3):347-56. PubMed ID: 25604624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity.
    Huh JR; Leung MW; Huang P; Ryan DA; Krout MR; Malapaka RR; Chow J; Manel N; Ciofani M; Kim SV; Cuesta A; Santori FR; Lafaille JJ; Xu HE; Gin DY; Rastinejad F; Littman DR
    Nature; 2011 Apr; 472(7344):486-90. PubMed ID: 21441909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 production.
    Fujita-Sato S; Ito S; Isobe T; Ohyama T; Wakabayashi K; Morishita K; Ando O; Isono F
    J Biol Chem; 2011 Sep; 286(36):31409-17. PubMed ID: 21733845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Th17 Cells with Small Molecules and Small Interference RNA.
    Lin H; Song P; Zhao Y; Xue LJ; Liu Y; Chu CQ
    Mediators Inflamm; 2015; 2015():290657. PubMed ID: 26792955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
    Zhang K; Guo Y; Ge Z; Zhang Z; Da Y; Li W; Zhang Z; Xue Z; Li Y; Ren Y; Jia L; Chan KH; Yang F; Yan J; Yao Z; Xu A; Zhang R
    Mol Neurobiol; 2017 Sep; 54(7):4908-4920. PubMed ID: 27514756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX-5 activates a novel RORγt enhancer to facilitate experimental autoimmune encephalomyelitis by promoting Th17 cell differentiation.
    Tian Y; Han C; Wei Z; Dong H; Shen X; Cui Y; Fu X; Tian Z; Wang S; Zhou J; Yang D; Sun Y; Yuan J; Ni B; Wu Y
    Nat Commun; 2021 Jan; 12(1):481. PubMed ID: 33473108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses.
    Ecoeur F; Weiss J; Kaupmann K; Hintermann S; Orain D; Guntermann C
    Front Immunol; 2019; 10():577. PubMed ID: 30972071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets.
    Wang J; Ren Z; Xu Y; Xiao S; Meydani SN; Wu D
    Am J Pathol; 2012 Jan; 180(1):221-34. PubMed ID: 22056360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune disease.
    Chang C; Loo CS; Zhao X; Solt LA; Liang Y; Bapat SP; Cho H; Kamenecka TM; Leblanc M; Atkins AR; Yu RT; Downes M; Burris TP; Evans RM; Zheng Y
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18528-18536. PubMed ID: 31455731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of RORγt
    Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
    Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing RORγt Activity and Suppressing Th17 Cell Differentiation.
    Ding Q; Zhao M; Yu B; Bai C; Huang Z
    PLoS One; 2015; 10(9):e0137711. PubMed ID: 26368822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
    Park TY; Park SD; Cho JY; Moon JS; Kim NY; Park K; Seong RH; Lee SW; Morio T; Bothwell AL; Lee SK
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18673-8. PubMed ID: 25527718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo.
    Guendisch U; Weiss J; Ecoeur F; Riker JC; Kaupmann K; Kallen J; Hintermann S; Orain D; Dawson J; Billich A; Guntermann C
    PLoS One; 2017; 12(11):e0188391. PubMed ID: 29155882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
    Codarri L; Gyülvészi G; Tosevski V; Hesske L; Fontana A; Magnenat L; Suter T; Becher B
    Nat Immunol; 2011 Jun; 12(6):560-7. PubMed ID: 21516112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-amino-acid substitution in the transcription factor RORγt disrupts its function in T
    He Z; Ma J; Wang R; Zhang J; Huang Z; Wang F; Sen S; Rothenberg EV; Sun Z
    Nat Immunol; 2017 Oct; 18(10):1128-1138. PubMed ID: 28846085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.